Advantages of Helicos BioSciences' single molecule sequencing technology presented

Download PDF Copy

Editorial Checklist

Reviewed

www.helicosbio.comDec 4 2009

Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that, as previously disclosed, it has posted a presentation on its website regarding the advantages of Helicos’ single molecule sequencing technology in clinical diagnostics. The presentation, made by Stanley N. Lapidus, Chairman of the Company, can be accessed through the investor relations section of the Company’s website at www.helicosbio.com. The presentation will be available on the website until January 4, 2010.

Source:

www.helicosbio.com

Posted in: Device / Technology News

Comments (0)

Download PDF Copy

Suggested Reading

Mount Sinai launches AI center to revolutionize small molecule drug discovery

Mount Sinai launches AI center to revolutionize small molecule drug discovery

This molecule links your diet to stroke and Alzheimer’s—here’s how to stop it

This molecule links your diet to stroke and Alzheimer’s—here’s how to stop it

Tampere University licenses drug for Epidermolysis Bullosa to Theravia

Tampere University licenses drug for Epidermolysis Bullosa to Theravia

Integrating video capsule endoscopy technology in probiotic research

Integrating video capsule endoscopy technology in probiotic research

Special class of RNA molecules may provide a new target to treat gastric cancer

Special class of RNA molecules may provide a new target to treat gastric cancer

Gastrolyzer® Range joins Selig De Colombia Portfolio, Expanding Access to Cutting-Edge Hydrogen Methane Breath Testing (HMBT) Technology

Gastrolyzer® Range joins Selig De Colombia Portfolio, Expanding Access to Cutting-Edge Hydrogen Methane Breath Testing (HMBT) Technology

Advancing Adherent Cell Assays with SemaCyte® Technology

Advancing Adherent Cell Assays with SemaCyte® Technology

Study uncovers mechanism for cognitive improvement in dementia

Study uncovers mechanism for cognitive improvement in dementia

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

New nanopore-based tool enables single molecule disease detection